Jagsonpal Pharmaceuticals to acquire India business of Resilient Cosmeceuticals

22 Feb 2025 Evaluate

Jagsonpal Pharmaceuticals has signed a Business Transfer Agreement to acquire the India business of Resilient Cosmeceuticals for a cash consideration of Rs 24 crore, to be funded from internal accruals. The company had a cash balance of Rs 132 crore as on December 31, 2024. 

The transaction is subject to customary closing conditions and is expected to close within 45 days. The acquisition gives access to a complimentary portfolio of Pharmaceuticals, Nutritional and Cosmetic products tapping into around Rs 1000 crore market opportunity in India.

Jagsonpal Pharmaceuticals is among India’s premiere pharmaceutical companies. The company has substantial research and development, manufacturing, marketing and distribution facilities. 


Jagsonpal Pharma Share Price

176.90 7.20 (4.24%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×